These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The fen-phen controversy: is regression another piece of the puzzle? Asinger RW Mayo Clin Proc; 1999 Dec; 74(12):1302-4. PubMed ID: 10593359 [No Abstract] [Full Text] [Related]
25. Valve disease and diet pills--where do we stand? Aurigemma GP; Gaasch WH Am Fam Physician; 1998 Feb; 57(4):656, 659-60. PubMed ID: 9490990 [No Abstract] [Full Text] [Related]
26. Longitudinal effects of fenfluramine-phentermine use. Bhattacharyya S; Constantin C; Davar J; Mikhailidis D Angiology; 2007 Dec-2008 Jan; 58(6):772-3; author reply 774. PubMed ID: 18216387 [No Abstract] [Full Text] [Related]
27. A dangerous duo? A combination of common diet drugs (fen-phen) may lead to heart valve disease. Boughner DR CMAJ; 1997 Sep; 157(6):705-6. PubMed ID: 9307558 [No Abstract] [Full Text] [Related]
28. [Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine]. Wolf I; Mouallem M; Farfel Z Harefuah; 1998 Dec; 135(11):515-7. PubMed ID: 10911468 [No Abstract] [Full Text] [Related]
29. [Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants]. Goldstein SE; Levy Y; Shoenfeld Y Harefuah; 1998 Dec; 135(11):489-92, 568. PubMed ID: 10911459 [TBL] [Abstract][Full Text] [Related]
31. The treatment of obesity with drugs. Hirsch J Am J Clin Nutr; 1998 Jan; 67(1):2-4. PubMed ID: 9440366 [No Abstract] [Full Text] [Related]
32. The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. Khan MA; Herzog CA; St Peter JV; Hartley GG; Madlon-Kay R; Dick CD; Asinger RW; Vessey JT N Engl J Med; 1998 Sep; 339(11):713-8. PubMed ID: 9731086 [TBL] [Abstract][Full Text] [Related]
33. Valvular heart disease with the use of fenfluramine-phentermine. Surapaneni P; Vinales KL; Najib MQ; Chaliki HP Tex Heart Inst J; 2011; 38(5):581-3. PubMed ID: 22163141 [TBL] [Abstract][Full Text] [Related]
34. Fen-phen and risk of valvular disease. SoRelle R Circulation; 1997 Sep; 96(6):1705-6. PubMed ID: 9323046 [No Abstract] [Full Text] [Related]
35. The "phen-pro" diet drug combination is not associated with valvular heart disease. Griffen L; Anchors M Arch Intern Med; 1998 Jun; 158(11):1278-9. PubMed ID: 9625413 [No Abstract] [Full Text] [Related]
36. Fen/phen and valvular heart disease: if it sounds too bad to be true, perhaps it isn't. Schiller NB J Am Coll Cardiol; 1999 Oct; 34(4):1159-62. PubMed ID: 10520806 [No Abstract] [Full Text] [Related]
37. Fen-phen's message to dentists. Hilsen K; Davis S; Iyer P J N J Dent Assoc; 1998; 69(1):37, 47. PubMed ID: 9584764 [No Abstract] [Full Text] [Related]
38. Fen-phen manufacturers, not physicians, are liable. Allen S; Henderson J Tex Med; 2000 May; 96(5):62-4. PubMed ID: 10843016 [No Abstract] [Full Text] [Related]
39. Fen-Phen-noumenon: A mass tort litigation and settlement about to come and go. Vaughan SF J Natl Med Assoc; 2002 Aug; 94(8 Suppl 2):C2-3. PubMed ID: 12185996 [No Abstract] [Full Text] [Related]